A61K 51/083
The peptide being octreotide or a somatostatin-receptor-binding peptide
Official title: {the peptide being octreotide or a somatostatin-receptor-binding peptide}
A61K51/083 (The peptide being octreotide or a somatostatin-receptor-binding peptide) appears on 175 US grants and 228 published applications in this corpus.
Search patents in A61K- Granted patents
- 175
- Published applications
- 228
- Assignees
- 117
- Inventors
- 453
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 5 | 0 |
| 1996 | 0 | 0 |
| 1997 | 6 | 0 |
| 1998 | 13 | 0 |
| 1999 | 13 | 0 |
| 2000 | 7 | 0 |
| 2001 | 11 | 1 |
| 2002 | 2 | 2 |
| 2003 | 1 | 1 |
| 2004 | 1 | 5 |
| 2005 | 1 | 3 |
| 2006 | 3 | 5 |
| 2007 | 2 | 5 |
| 2008 | 1 | 1 |
| 2009 | 2 | 4 |
| 2010 | 0 | 2 |
| 2011 | 3 | 4 |
| 2012 | 5 | 7 |
| 2013 | 9 | 6 |
| 2014 | 4 | 11 |
| 2015 | 2 | 7 |
| 2016 | 5 | 7 |
| 2017 | 3 | 4 |
| 2018 | 7 | 11 |
| 2019 | 7 | 7 |
| 2020 | 5 | 20 |
| 2021 | 5 | 10 |
| 2022 | 7 | 19 |
| 2023 | 10 | 16 |
| 2024 | 14 | 23 |
| 2025 | 15 | 30 |
| 2026 | 5 | 17 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Copper-64 compositions and formulations25 Aug 2026US 12,718,963 B1Curium US LLC
- Somatostatin receptor-based cancer therapy28 Jul 2026US 12,691,179 B2Vikas Kundra
- High purity copper radiopharmaceutical compositions and diagnostic and therapeutic uses thereof12 May 2026US 12,622,984 B2Nuclidium AG
- High purity copper radiopharmaceutical compositions and diagnostic and therapeutic uses thereof20 Jan 2026US 12,527,885 B2Nuclidium AG
- Stable radiopharmaceutical compositions and uses thereof6 Jan 2026US 12,514,939 B2Alpha-9 Oncology, Inc.
- Zwitterionic metal chelators3 Sep 2026US 2026/0256958 A1Curadel Surgical Innovations, Inc.
- Method of treatment of neuroendocrine tumors3 Sep 2026US 2026/0256961 A1Advanced Accelerator Applications SA
- Dual receptor targeting radioligands and uses thereof related applications27 Aug 2026US 2026/0248972 A1Full-Life Technologies HK Limited
- Somatostatin binding compositions and methods of use thereof6 Aug 2026US 2026/0224760 A1Ratio Therapeutics, Inc.
- Radiolabeled medicine30 Jul 2026US 2026/0216383 A1National University Corporation Chiba University
Most cited
By later US patents
- Peptide-metal ion pharmaceutical preparation and method93US 5,443,816 ARhomed Incorporated · 1995
- Technetium-99m labeled somatostatin-derived peptides for imaging71US 5,225,180 ADiatech, Inc. · 1993
- Peptide conjugate70US 5,442,043 ATakeda Chemical Industries, Ltd. · 1995
- Radiolabelled peptide compounds65US 5,382,654 AMallinckrodt Medical, Inc. · 1995
- Method to enhance tissue accumulation of radiolabeled compounds61US 6,180,082 B2Board of Supervisors of Louisiana State University and Agricultural and Mechanical College · 2001